Explore more publications!

Latin American Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin American Newswire.

Press releases published on December 2, 2025

GeeFi (GEE) $650K Raised Milestone Creates Headlines, Reaching Institutional Interest
México y la desigualdad salarial: por qué personas con el mismo título ganan sueldos distintos
ARH Global Advisors Strengthens Manhattan Advisory Services for International Real Estate Investors
ARH Global Advisors Expands Manhattan Fiduciary Wealth Advisory Services
ARH Global Advisors Introduces Dedicated Manhattan Advisory Services for Attorneys, Law Firms & Fiduciary Professionals
Ripple (XRP) Holders Eye GeeFi (GEE) as Presale Rises Over $650K in Little Over a Week
Yerba Mate Market 2032 : Regional Share, Industry Size and Future Growth
Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases
Total Voting Rights and Notification of Transactions of a Persons Discharging Managerial Responsibilities (PDMR)
LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc.
Creative Medical Technology Holdings Announces World Health Organization Approval of “olastrocel” as INN for Lead Allogeneic Cell Therapy CELZ-201
FEMSA Announces Accelerated Share Repurchase Agreement
FEMSA Anuncia Acuerdo de Recompra Acelerada de Acciones
GoldHaven Resources Completes Eight Diamond Drill Holes at Copeçal Gold Project in Brazil: Ninth Hole Underway To Follow Up Sulphide Intersection in Hole 4 East Target
ADARx Pharmaceuticals Appoints Mary Tagliaferri, M.D., to its Board of Directors
Palisade Bio Strengthens Clinical Leadership Team with Appointment of James Izanec, MD, AGAF as Vice President, Clinical Development
Biofrontera Inc. Announces Filing of Supplemental New Drug Application (sNDA) for the Treatment of Superficial Basal Cell Carcinoma (sBCC) with Ameluz®-PDT
Alpha Capital Invests in VIXO Protocol to Advance Privacy-Optional Decentralized Stable Finance Infrastructure
PDS Biotech Announces Scheduling of Type C Meeting with U.S. Food and Drug Administration (“FDA”)
Fulcrum Therapeutics to Host Investor Event to Review New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease on December 7, 2025

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions